Delivery Order SPE2DE24D0013-SPE2D625F9NC1
- Not listed
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- This delivery order, valued at $2,500, was awarded to Cepheid Inc. on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division for completion by July 30, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will deliver products or services under this order, which represents a relatively modest purchase within the company's broader federal...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, valued at $11,040.00, is a firm fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract is for the delivery of Cepheid's molecular diagnostic systems and associated services, primarily focused on detecting infectious diseases such as COVID-19, influenza, and sexually...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as...
- This delivery order, valued at $13.6K, was awarded on July 21, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, by the Medical Supply Chain within the Department of Defense. The contract, which carries no set-aside designation and employs firm fixed-price terms, is scheduled for completion by July 28, 2025. Based on the contract nomenclature (XPCOV2/FLU/RSV-10), this delivery order pertains to diagnostic testing for COVID-19, influenza, and...
- This delivery order, awarded July 28, 2025, represents a $3,400 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California. The order is designated for respiratory pathogen testing, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed by August 4, 2025. No set-aside designation was applied to this procurement....
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $20.4K to Cepheid Inc. on July 25, 2025, for molecular diagnostic solutions. Designated as Contract Number 4568895371 with the identifier XPCOV2/FLU/RSV-10, this firm fixed-price delivery order is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostics testing solutions, specifically targeting...
- This delivery order, valued at $1,840 and awarded to Cepheid Inc. on July 25, 2025, represents a firm fixed-price procurement under the Medical Supply Chain, a Defense agency funding source. The contract is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. As a leading manufacturer of molecular diagnostic solutions, Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, providing...
- Cepheid has been awarded a delivery order valued at $7,276 under contract number 4568920470 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This firm fixed-price delivery order, issued by the Medical Supply Chain division of the Department of Defense, will be performed in Sunnyvale, California, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation and represents a continuation of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F9NC1Delivery Order
This delivery order, awarded July 30, 2025, by the Defense Logistics Agency (under the Medical Supply Chain operations) to Cepheid Inc., carries a firm fixed-price ceiling value of $27,235.80 with an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and is performed in Sunnyvale, California, where Cepheid maintains its headquarters. Cepheid, a for-profit manufacturer of molecular diagnostic solutions, will deliver products or services under this delivery order, which represents a task order against one of the company's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs or a related federal health procurement vehicle. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with a proven track record supporting federal healthcare agencies including the VA, Indian Health Service, and Defense Logistics Agency. The company's core offerings include GeneXpert diagnostic systems, molecular reagents, test kits, and maintenance services designed to detect conditions such as COVID-19, influenza, RSV, and other infectious diseases. This delivery order aligns with Cepheid's established role as a supplier of molecular diagnostic technologies to the federal healthcare system and reflects the company's competitive position in the molecular diagnostics market for defense and civilian federal health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 7/30/25 |